首頁 > 市場調查報告書 > 醫療設備

心血管設備

市場調查報告書

商品編碼

1441209

全球心臟幫浦設備市場規模、佔有率、成長分析、按產品類型、按適應症、按最終用戶 - 產業預測，2023-2030 年

Global Heart Pump Device Market Size, Share, Growth Analysis, By Product Type(Ventricular assist devices, Intra-aortic balloon pumps ), By Indication(Bridge-to-transplant, Destination therapy ), By End-user - Industry Forecast 2023-2030

出版日期: 2024年02月19日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2022年全球心泵設備市場規模為20.9億美元，從2023年的26.1億美元成長到2031年的153.2億美元，預測期內（2024-2031年）複合年成長率為24.77%。

全球心臟泵設備市場正在全球範圍內經歷顯著成長。該報告涵蓋了心臟泵設備市場價值鏈分析的詳細資訊，並為製造商提供了競爭考察，以在預測期內獲得競爭優勢。這一市場成長的主要驅動力是全球心血管疾病盛行率的不斷上升。隨著心臟衰竭盛行率的持續上升，對心臟泵設備的需求顯著增加，心臟泵設備在支持和維持嚴重心臟疾病患者的心臟功能方面發揮關鍵作用。人口老化加劇，更容易罹患心臟病，進一步促進了市場擴張。除了高疾病負擔之外，心臟幫浦技術的進步也推動了市場的發展。心臟幫浦設備的尺寸較小、耐用性更高和功能增強等技術創新正在顯著改善患者的治療效果並推動更多的採用。例如，磁浮輔助人工心臟(VAD) 的開拓透過更好地支持衰弱的心臟同時降低併發症的風險，徹底改變了市場。心臟泵設備市場也看到機械循環支援設備的快速採用。隨著晚期心臟衰竭患者數量的不斷增加，對長期機械支援的需求變得非常重要。機械循環支援裝置，包括輔助人工心臟裝置 (VAD) 和全人工心臟 (TAH)，為等待心臟移植的患者或被認為不適合移植的患者提供了生命線。隨著目的地治療的日益接受，市場進一步擴大，其中機械循環支持裝置成為合格移植的患者的永久解決方案。

市場概況
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東/非洲
- 海灣合作理事會國家
- 南非
- 其他中東/非洲地區

競爭格局

前5名企業對比
主要企業市場定位（2021年）
主要市場參與者所採取的策略
關鍵成功策略
近期市集活動
主要企業市場佔有率（2021年）

主要企業簡介

雅培實驗室（美國）
美敦力公司（愛爾蘭）
LivaNova PLC（英國）
柏林之心有限公司（德國）
SynCardia Systems, LLC（美國）
Abiomed, Inc.（美國）
Getinge AB（瑞典）
泰爾茂株式會社（日本）
泰利福公司（美國）
賈維克心臟公司（美國）
Fresenius Medical Care AG & Co. KGaA（德國）
凱隆有氧運動（英國）
CardiacAssist, Inc.（美國）
BiVACOR Inc.（澳洲）
Leviticus Cardio Ltd.（以色列）
CARMAT SA（法國）
FineHeart SA（法國）
邁爾瓦德（美國）
微創醫療科技有限公司 (中國)
TandemLife，LivaNova 公司（美國）

簡介目錄

Product Code: SQMIG35A2376

Global Heart Pump Device Market size was valued at USD 2.09 Billion in 2022 and is poised to grow from USD 2.61 Billion in 2023 to USD 15.32 Billion by 2031, at a CAGR of 24.77% during the forecast period (2024-2031).

The global heart pump device market is witnessing substantial growth on a global scale. Our report encompasses detailed information on the value chain analysis for the Heart Pump Device market, providing manufacturers with insights to gain a competitive edge over the projected period. The primary driving force behind this market growth is the increasing prevalence of cardiovascular diseases on a global scale. As the incidence of heart failure continues to rise, the demand for heart pump devices has seen a significant upswing, given their crucial role in supporting and maintaining heart function in patients with severe cardiac conditions. The expanding aging population, more susceptible to heart ailments, further contributes to the market's expansion. In addition to the high disease burden, advancements in heart pump technology have propelled the market forward. Innovations such as miniaturization, improved durability, and enhanced functionality of heart pump devices have substantially improved patient outcomes, fostering increased adoption. For instance, the development of magnetically levitated ventricular assist devices (VADs) has revolutionized the market by providing better support to weakened hearts while reducing the risk of complications. The heart pump device market is also witnessing a surge in the adoption of mechanical circulatory support devices. With the increasing prevalence of advanced heart failure cases, the demand for long-term mechanical support has become critical. Mechanical circulatory support devices, including ventricular assist devices (VADs) and total artificial hearts (TAHs), offer a lifeline to patients awaiting heart transplantation or those deemed unsuitable candidates for transplantation. The growing acceptance of destination therapy, where mechanical circulatory support devices serve as a permanent solution for patient's ineligible for transplant, has further expanded the market's reach.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Heart Pump Device Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analysed to get the final quantitative and qualitative data.

Global Heart Pump Device Market Segmental Analysis

The global Heart Pump Device market can be segmented based on product type, indication, end-user, and region. Based on product type, the market can be divided into ventricular assist devices (VADs), intra-aortic balloon pumps (IABPs), total artificial heart (TAH). Based on indication, the market can be categorized into bridge-to-transplant (BTT), destination therapy (DT), bridge-to-recovery (BTR). Based on end-user, the market can be categorized into hospitals, cardiology centers, ambulatory surgical centres. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Heart Pump Device Market

Continuous innovation and ongoing advancements in heart pump technology have notably enhanced the performance and outcomes of these devices. Technological progress has given rise to the development of smaller, more durable, and more efficient heart pump devices, ultimately leading to improved patient comfort and an enhanced quality of life. A notable example is the introduction of magnetically levitated ventricular assist devices (LVADs), which has effectively reduced device-related complications and contributed to improved patient outcomes.

Restraints in the Global Heart Pump Device Market

Heart pump devices are intricate and advanced medical technologies, leading to high manufacturing and acquisition costs. The elevated expenses associated with heart pump devices present a substantial financial burden for patients, healthcare providers, and healthcare systems. Additionally, challenges arise from the limited reimbursement coverage for these devices in certain regions, creating obstacles for patients seeking access to these life-saving technologies.

Market Trends of the Global Heart Pump Device Market

Devices that are compatible with heart pump systems are engineered to work seamlessly, optimizing their performance and ensuring efficient functioning. For instance, advanced control units are capable of providing precise management of pump flow and parameters, contributing to enhanced patient outcomes. Similarly, power sources that are compatible can offer extended battery life and a reliable power supply, thereby minimizing interruptions related to the device. These compatible devices often come equipped with advanced monitoring and data management capabilities, enabling real-time remote monitoring. This capability allows healthcare professionals to track patient status and make more informed decisions.

Executive Summary

Market Overview
Wheel of Fortune

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Parent Market Analysis

Market Overview
Market Size
Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges

Key Market Insights

Technology Analysis
Pricing Analysis
Supply Chain Analysis
Value Chain Analysis
Ecosystem of the Market
IP Analysis
Trade Analysis
Startup Analysis
Raw Material Analysis
Innovation Matrix
Pipeline Product Analysis
Macroeconomic Indicators
Top Investment Analysis
Key Success Factor
Degree of Competition

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Regulatory Landscape
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact

Global Heart Pump Device Market by Product Type

Market Overview
Ventricular assist devices (VADs)
Intra-aortic balloon pumps (IABPs)
Total artificial heart (TAH)

Global Heart Pump Device Market by Indication

Market Overview
Bridge-to-transplant (BTT)
Destination therapy (DT)
Bridge-to-recovery (BTR)

Global Heart Pump Device Market by End-user

Market Overview
Hospitals
cardiology centers
ambulatory surgical centers

Global Heart Pump Device Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2021
Strategies Adopted by Key Market Players
Top Winning Strategies
- By Development
- By Company
- By Year
Recent Activities in the Market
Key Companies Market Share (%), 2021

Key Company Profiles

Abbott Laboratories (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic PLC (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
LivaNova PLC (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Berlin Heart GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SynCardia Systems, LLC (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abiomed, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Getinge AB (Sweden)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Terumo Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Teleflex Incorporated (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Jarvik Heart, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fresenius Medical Care AG & Co. KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Calon Cardio (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CardiacAssist, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BiVACOR Inc. (Australia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Leviticus Cardio Ltd. (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CARMAT SA (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
FineHeart SA (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MyLVAD (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MicroPort Scientific Corporation (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
TandemLife, a LivaNova company (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments